Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
Madeline M Keenen,1 Suwon Kim1,2 1Department of Basic Medical Sciences, University of Arizona College of Medicine – Phoenix, Phoenix, AZ, 2Division of Cancer and Cell Biology, Translational Genomics Research Institute, Phoenix, AZ, USA Abstract: Resistance to antiestrogen therapy remains a...
Guardado en:
Autores principales: | Keenen MM, Kim S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/461a180658264d96acad0768a734ce04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells
por: Hallman K, et al.
Publicado: (2017) -
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin A, et al.
Publicado: (2020) -
Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
por: Lower EE, et al.
Publicado: (2017) -
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
por: Casneuf T, et al.
Publicado: (2016) -
Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases
por: Tsunoda Y, et al.
Publicado: (2018)